» Articles » PMID: 32462258

Kidney Replacement Therapy in Pediatric Patients on Mechanical Circulatory Support: Challenges for the Pediatric Nephrologist

Overview
Journal Pediatr Nephrol
Specialties Nephrology
Pediatrics
Date 2020 May 29
PMID 32462258
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

The use of mechanical circulatory support (MCS) therapies in children with medically refractory cardiac failure has increased over the past two decades. With the growing experience and expertise, MCS is currently offered as a bridge to recovery or heart transplantation and in some cases even as destination therapy. Acute kidney injury (AKI) is common in patients with end-stage heart failure (ESHF). When severe AKI develops requiring kidney replacement therapy (KRT), these patients present unique challenges for the pediatric nephrology team. The use of KRT has not been adequately described in children with ESHF on the newer MCS. We also present original case series data from our center experience. The purpose of this review is to familiarize the reader with the current MCS technologies, approach to their selection, how they interact when combined with current KRT circuits, and distinguish similarities and differences. We will attempt to highlight the distinctive features of each technology, specifically focusing on growing trends in use of continuous-flow ventricular assist devices (CF-VAD) as it poses additional challenges to the pediatric nephrologist.

Citing Articles

Long-term kidney outcomes in pediatric continuous-flow ventricular assist device patients.

Idrovo A, Hollander S, Neumayr T, Bell C, Munoz G, Choudhry S Pediatr Nephrol. 2023; 39(4):1289-1300.

PMID: 37971519 DOI: 10.1007/s00467-023-06190-8.

References
1.
OConnor M, Rossano J . Ventricular assist devices in children. Curr Opin Cardiol. 2013; 29(1):113-21. DOI: 10.1097/HCO.0000000000000030. View

2.
Wehman B, Stafford K, Bittle G, Kon Z, Evans C, Rajagopal K . Modern Outcomes of Mechanical Circulatory Support as a Bridge to Pediatric Heart Transplantation. Ann Thorac Surg. 2016; 101(6):2321-7. PMC: 5524136. DOI: 10.1016/j.athoracsur.2015.12.003. View

3.
Burki S, Adachi I . Pediatric ventricular assist devices: current challenges and future prospects. Vasc Health Risk Manag. 2017; 13:177-185. PMC: 5437969. DOI: 10.2147/VHRM.S82379. View

4.
Rossano J, Cherikh W, Chambers D, Goldfarb S, Hayes Jr D, Khush K . The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-first pediatric heart transplantation report-2018; Focus theme: Multiorgan Transplantation. J Heart Lung Transplant. 2018; 37(10):1184-1195. DOI: 10.1016/j.healun.2018.07.018. View

5.
Prodhan P, Bhutta A, Gossett J, Dodgen A, Seib P, Imamura M . Comparative effects of ventricular assist device and extracorporeal membrane oxygenation on renal function in pediatric heart failure. Ann Thorac Surg. 2013; 96(4):1428-1434. DOI: 10.1016/j.athoracsur.2013.05.083. View